Covid-19: Winter Plan Debate

Full Debate: Read Full Debate
Department: Cabinet Office

Covid-19: Winter Plan

Tom Hunt Excerpts
Monday 23rd November 2020

(4 years ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Matt Hancock Portrait Matt Hancock
- Hansard - - - Excerpts

Yes, I will absolutely take the hon. Gentleman’s points on board in the conversations that Ministers are having across the devolved nations of the United Kingdom, including his point about the enormous number of ties, including family ties, between the UK and Republic of Ireland. As he knows, the common travel area is there between the UK and the Republic, so travel to the Republic from the UK side has never been restricted. That is a point of principle and policy, and I know that it is important for the people of Northern Ireland.

Tom Hunt Portrait Tom Hunt (Ipswich) (Con)
- Hansard - -

It is welcome news that Ipswich Hospital found out on 11 November that it would be receiving £5.2 million for a new molecular laboratory. This will allow the hospital to ramp up rapid testing to almost 3,000 a day by the end of March. We have also heard reports that Suffolk’s first site for delivering vaccinations will be ready in two weeks’ time, with the NHS proposing the Gainsborough sports centre in Ipswich. Testing and vaccinations are two crucial ways to beat the virus, so does my right hon. Friend agree that having Ipswich at the forefront of both these key issues will be a real boost to Ipswich residents?

Matt Hancock Portrait Matt Hancock
- Hansard - - - Excerpts

We have put millions of pounds into Ipswich Hospital, and I know that my hon. Friend supports Ipswich Hospital very strongly indeed. I am glad that across Suffolk and across the whole of the country we are now putting in place the vaccination hubs that will be there and ready, should the regulator sign off a new vaccine. I do not want to intrude on the rigorous independence of the medical regulator—the Medicines and Healthcare Products Regulatory Agency, which will make the decision on the safety of these vaccines—but should it be approved, the NHS will be ready to begin the roll-out and I set the NHS the challenge of ensuring that it can roll out at the speed at which these vaccines can be manufactured and produced.